Arcadia Biosciences
RKDA
Arcadia Biosciences (RKDA) - Cash on Hand
Cash on Hand as of December 2023 : $11.64 M
According to Arcadia Biosciences's latest financial reports the company has $11.64 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Arcadia Biosciences - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $20.64 M | -28.03% |
| 2021-12-31 | $28.68 M | 11.76% |
| 2020-12-31 | $25.66 M | 1.32% |
| 2019-12-31 | $25.33 M | 16.08% |
| 2018-12-31 | $21.82 M | 67.57% |
| 2017-12-31 | $13.02 M | -74.24% |
| 2016-12-31 | $50.56 M | 0.63% |
| 2015-12-31 | $50.24 M | 203.2% |
| 2014-12-31 | $16.57 M | 484.51% |
| 2013-12-31 | $2.83 M | -47.01% |
| 2012-12-31 | $5.35 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Marrone Bio Innovations
MBII | N/A | N/A | 🇺🇸 USA |
 Codexis
CDXS | $65.11 M | 459.32% | 🇺🇸 USA |
 ScottsMiracle-Gro SMG | $10.4 M | -10.67% | 🇺🇸 USA |
 American Vanguard AVD | $11.41 M | -1.94% | 🇺🇸 USA |